A medication prevents blood clots in patients with non-valvular atrial fibrillation and treats deep vein thrombosis or pulmonary embolism.
Indications:
- Preventing stroke and systemic embolism in patients with non-valvular atrial fibrillation.
- Treating deep vein thrombosis (DVT) and pulmonary embolism (PE).
- Reducing the risk of recurrent DVT and PE.
Main Active Ingredient:
- Apixaban 2.5mg.
Precautions:
- Increased risk of bleeding, especially in patients with kidney problems or taking other medications that affect bleeding.
- Not recommended for patients with severe kidney disease or active pathological bleeding.
- Discontinue use if bleeding occurs.
- Monitor kidney function regularly.
Side Effects:
- Bleeding (major or minor).
- Anemia.
- Nausea.
- Headache.
- Fatigue.
Drug-Drug Interactions:
- Anticoagulants .
- Antiplatelet.
- Certain antifungal medications.
- Certain HIV medications .
Apixaban,Anhydrous lactose, Microcrystalline cellulose,Croscarmellose sodium,Sodium lauryl sulfate,Magnesium stearate,Lactose monohydrate, Hypromellose,Titanium dioxide,Triacetin,Yellow iron oxide.